SCNI
Scinai Immunotherapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.72
−3.80%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.43x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.08x
- Price / sales
- 0.66x
- Price / cash flow
- -0.13x
Enterprise value
- Enterprise value
- $7.3M
- EV / sales
- 4.91x
- EV / EBITDA
- -1.10x
- EV / EBIT
- -0.87x
- Market cap
- $979.5K
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026